Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zamaneh Mikhak Insider Profile
4 Followers
Zamaneh Mikhak, CMO at TFF Pharmaceuticals, holds 135.00K shares in TFF Pharmaceuticals (Ticker: TFFP). Most recently, Zamaneh Mikhak Bought $120,000 shares of TFF Pharmaceuticals on Aug 15, 2023 for an estimated value of 30.00K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-65.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CMO
Roles that Zamaneh Mikhak holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 13, 2023 - Mar 13, 2024
Return:-59.90%
The most profitable trade made by Zamaneh Mikhak
Zamaneh Mikhak's Trading History
List of latest transactions for each holding click on a transaction to see Zamaneh Mikhak's performance on stock
You May Also Like
Zamaneh Mikhak insider profile FAQ
What is the percentage of profitable transactions made by Zamaneh Mikhak?
The percentage of profitable transactions made by Zamaneh Mikhak is 0%.
What is the average return per transaction made by Zamaneh Mikhak?
The average return per transaction made by Zamaneh Mikhak is -65.70%.
What stocks does Zamaneh Mikhak hold?
Zamaneh Mikhak holds: TFFP stocks.
What was Zamaneh Mikhak’s latest transaction?
Zamaneh Mikhak latest transaction was an Informative Buy of $30.00K.
What was Zamaneh Mikhak's most profitable transaction?
Zamaneh Mikhak’s most profitable transaction was an Informative Buy of TFFP stock on March 13, 2023. The return on the trade was -59.90%.
What is Zamaneh Mikhak's role in TFF Pharmaceuticals?
Zamaneh Mikhak's role in TFF Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.